Mortality or serious adverse events requiring hospital admission · people with radicular low back pain (not due to spinal stenosis)
It is very uncertain whether systemic corticosteroids changes participants who experienced a serious adverse event Adverse event… compared with placebo (very low certainty).
1 finding from 1 review
Participants with hyperglycemia "Transient hyperglycemia" or blood sugar increase ≥ 50 mg/dL · people with radicular low back pain (not due to spinal stenosis)
Systemic corticosteroids showed no clear difference in participants with hyperglycemia "Transient hyperglycemia" or blood… compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · people with non‐radicular low back pain
1 finding from 1 review
Pain (dichotomous) No pain in last 24 hours · people with non‐radicular low back pain
Systemic corticosteroids showed no clear difference in pain (dichotomous) No pain in last 24 hours compared with placebo (low certainty).
1 finding from 1 review
Breathlessness (dyspnoea) at 1 week (intensity) Scale 0–10; lower score = less breathlessness · adults with cancer‐related breathlessness (dyspnoea)
1 finding from 1 review
Dyspnea · adults with cancer‐related breathlessness (dyspnoea)
2 findings from 1 review
Adverse events · adults with cancer‐related breathlessness (dyspnoea)
1 finding from 1 review
Patient satisfaction with treatment · adults with cancer‐related breathlessness (dyspnoea)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals (parallel group trials/first arm cross‐over trials) · adults with cancer‐related breathlessness (dyspnoea)
1 finding from 1 review
Day 5 · children with acute otitis media
1 finding from 1 review
Day 14 · children with acute otitis media
1 finding from 1 review
Reduction in overall or specific symptom duration · children with acute otitis media
1 finding from 1 review
Adverse effects · children with acute otitis media
1 finding from 1 review
Change in hearing threshold determined by PTA Range 0 dB to 140 dB Negative values represent lowering and positive values represent raising of the hearing threshold. A lower hearing threshold represents hearing improvement. Â · sudden sensorineural hearing loss
Intratympanic plus systemic corticosteroids (combined therapy) showed no clear difference in change in hearing threshold determined by PTA Range 0 dB to 140 dB… compared with systemic corticosteroids alone (low certainty).
2 findings from 1 review
Proportion of patients whose hearing is improved · sudden sensorineural hearing loss
It is very uncertain whether intratympanic plus systemic corticosteroids (combined therapy) changes proportion of patients whose hearing is improved compared with systemic corticosteroids alone (very low certainty).
2 findings from 1 review
Final hearing threshold determined by PTA (a lower value represents better hearing) · sudden sensorineural hearing loss
It is very uncertain whether intratympanic plus systemic corticosteroids (combined therapy) changes final hearing threshold determined by PTA A lower value represents… compared with systemic corticosteroids alone (very low certainty).
2 findings from 1 review
Adverse eventsb · sudden sensorineural hearing loss
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Persistent tympanic membrane perforation · sudden sensorineural hearing loss
2 findings from 1 review
Vertigo/dizziness: timing not reported · sudden sensorineural hearing loss
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Vertigo/dizziness: at the time of injection · sudden sensorineural hearing loss
2 findings from 1 review